Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Publication year range
1.
J Med Food ; 24(2): 172-179, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33617364

ABSTRACT

In this study, we investigated the lipolytic effects of an Emblica officinalis (Indian gooseberry [IG]) and Hordeum vulgare L. (barley sprout [BP]) mixture on differentiated 3T3-L1 cells. On the ninth day of differentiation, Oil red O staining and Western blotting were performed; additionally, glycerol release and triglyceride (TG), fatty acid (FA), and cyclic adenosine monophosphate (cAMP) levels were measured. Compared to the differentiation-induced control (C) group, the IG and BP mixture inhibited intracellular TG and FA levels by 61.7% and 48.9%, respectively, at a concentration of 200 µg/mL. Moreover, the mixture increased glycerol release and cAMP levels by more than twofold more than those in the C group. Western blotting was performed to confirm the protein expression involved in lipolysis, and the IG and BP mixture was found to significantly increase the protein activities of AMP-activated protein kinase, protein kinase A, and hormone-sensitive lipase compared to those of the C group. Furthermore, the mixture significantly inhibited the protein activities of phosphodiesterase 3B, adipose TG lipase, and perilipin compared to those of the C group at a concentration of 200 µg/mL. We found that the IG and BP mixture activates the cAMP pathway and regulates lipolytic enzymes, which are necessary for lipolysis. In conclusion, our findings suggest that the IG and BP mixture can be potentially developed as a new material for targeting mechanisms underlying lipolysis.


Subject(s)
Hordeum , Lipolysis , Phyllanthus emblica , Plant Extracts , 3T3-L1 Cells , Animals , Enzymes/genetics , Enzymes/metabolism , Gene Expression Regulation, Enzymologic/drug effects , Hordeum/chemistry , Lipolysis/drug effects , Mice , Phyllanthus emblica/chemistry , Plant Extracts/pharmacology
2.
Medicine (Baltimore) ; 99(24): e20568, 2020 Jun 12.
Article in English | MEDLINE | ID: mdl-32541484

ABSTRACT

RATIONALE: Skin photobiomodulation involves the use of low doses of light of a specific wavelength to reduce skin inflammation and promote tissue repair. Recently, a face mask using a light-emitting diode (LED) to induce photobiomodulation has been widely introduced in the market. However, a short wavelength of high-energy blue light can cause retinal damage. We would like to report a rare case of photochemical retinopathy after using a blue LED face mask. PATIENT CONCERNS: A 37-year-old woman presented with complaints of distorted vision. The patient was exposed to blue light from an LED face mask 1 month before presentation. DIAGNOSIS: Color fundus photography revealed a yellowish chorioretinal lesion and optical coherence tomography revealed retinal pigment epithelium destruction in the parafoveal area. Fluorescein angiography revealed leakage from the lesion at the parafovea. The patient was diagnosed with blue LED-induced photochemical retinopathy. INTERVENTIONS: Intravitreal bevacizumab was injected in the right eye. OUTCOMES: After 4 weeks, dysmorphopsia was improved. LESSONS: This case report demonstrates that retinal damage can occur in humans due to prolonged exposure to blue light. Therefore, it is important to be wary of eye exposure and ensure the eyes are covered during LED face mask use.


Subject(s)
Light/adverse effects , Low-Level Light Therapy/adverse effects , Retinal Diseases/etiology , Adult , Female , Humans , Retinal Diseases/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL